A proof-of-concept study suggests the possibility of engineering artificial ovaries in the lab to provide a more natural option for hormone replacement therapy for women. In Biomaterials, a team from Wake Forest Baptist Medica ...
5 / 5 (3) |
0
|
Most first-time mothers wait until after 6 weeks postpartum to resume vaginal sex following childbirth and women who have an operative vaginal birth, caesarean section, perineal tear or episiotomy appear to wait longer, suggests ...
not rated yet |
0
A novel head-to-head study looking at differences in how the antiretroviral (ARV) drug tenofovir gets absorbed in the body as either an oral tablet or a vaginal gel found tenofovir gel can achieve substantially higher concentrations ...
not rated yet |
0
"Hooking up" has become such a trend on college campuses that some believe these casual, no-strings-attached sexual encounters may be replacing traditional romantic relationships. However, a new study by researchers with ...
not rated yet |
0
Prostate cancer survivors and their partners experience improved sexual satisfaction and function after couples counseling, according to research at The University of Texas MD Anderson Cancer Center. The article, ...
not rated yet |
0
Partner abuse leads to HIV infection, and black women are most at risk. A new study at the University of Pennsylvania School of Nursing has found that 46 percent of African-American adolescent girls report that their partner ...
not rated yet |
0
A gel formulation of the antiretroviral drug tenofovir designed specifically for rectal use was found safe and acceptable, according to a Phase I clinical study led by the U.S. National Institutes of Health (NIH)-funded Microbicide ...
not rated yet |
0
A change in the formulation of tenofovir gel, an anti-HIV gel developed for vaginal use, may make it safer to use in the rectum, suggests a study published online this week in the Journal of Antimicrobial Chemotherapy. In lab ...
5 / 5 (1) |
0
Determining whether a promising HIV prevention gel is safe for women to use while they are pregnant or breastfeeding is the aim of a new clinical trial being conducted by the National Institutes of Health-funded Microbicide ...
not rated yet |
0
In the first clinical trial of a vaginal ring combining two antiretroviral (ARV) drugs, researchers from the Microbicide Trials Network (MTN) are collaborating with the International Partnership for Microbicides (IPM) to ...
not rated yet |
0
